The Accuracy of Ultrasound in the Detection of Placenta Site in the First Trimester.
Launched by ASSAF-HAROFEH MEDICAL CENTER · Oct 2, 2020
Trial Information
Current as of July 25, 2025
Suspended
Keywords
ClinConnect Summary
All women with a first trimester missed abortion who will sign an informed consent form will undergo an ultrasound examination. During the examination, the operator will assess the location of the placenta/sac insertion. After the performance of the ultrasound, the women will undergo hysteroscopy with a different operator who will be blinded to the results of the previous exam result. During the hysteroscopy the second operator will assess again the location of the sac insertion .The investigatorswill then compare the results of the two tests using the histeroscopy as the gold standard and ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy women .
- • Clinical diagnosis of first trimester spontaneous abortion.
- Exclusion Criteria:
- • viable pregnancy
- • women below 18 years
- • women with chronic disease
About Assaf Harofeh Medical Center
Assaf-Harofeh Medical Center is a prominent healthcare institution located in Israel, renowned for its commitment to advancing medical research and improving patient care. As a key sponsor of clinical trials, the center focuses on a diverse range of therapeutic areas, leveraging its state-of-the-art facilities and interdisciplinary expertise to facilitate innovative studies. With a dedicated team of experienced researchers and clinicians, Assaf-Harofeh Medical Center is dedicated to fostering scientific breakthroughs that enhance treatment outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zrifin, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials